Market Place
Sourcing Support
Imbria hits goal in angina trial days after heart failure win
13 Nov 2023 //
FIERCE BIOTECH
Imbria touts PhII success in hypertrophic cardiomyopathy
08 Nov 2023 //
ENDPTS
Imbria hits safety benchmark in phase 2 heart failure test
07 Nov 2023 //
FIERCE BIOTECH
Imbria Pharmaceuticals Appoints John Young to Its Board of Directors
24 Mar 2022 //
BUSINESSWIRE
Imbria Pharma to Participate at SVB Leerink Biopharma Private Company Connect
22 Mar 2022 //
BUSINESSWIRE
Imbria Announces Initiation of Enrollment in IMPROVE-HCM
19 Jul 2021 //
BUSINESSWIRE
Imbria Pharma Announces Enrolment of the First 10 Patients in IMPROVE-DiCE
22 Jun 2021 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.